<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-114971</identifier>
<setSpec>0214-9168</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Biomarkers in acute coronary syndromes with and without ST elevation</dc:title>
<dc:description xml:lang="en">Introduction and objectives. Acute coronary syndrome involves an inflammatory process which has several analytical markers. Knowledge of those could help us improve the risk classification and choose the most appropriate treatment. Methods. A total of 151 consecutive patients with STE-ACS and NSTE-ACS (ST elevated and non-ST elevated acute coronary syndrome) were studied. The classic cardiovascular risk factors (diabetes mellitus, high blood pressure, family and personal history and smoking habits) were determined along with several analytical markers, among which were included insulin, fibrinogen, C-reactive protein, Lp(a) and erythrocyte sedimentation rate. Results. Of the total pateints, 88 (58.3%) had NSTE-ACS and 63 (41.7%) with STE-ACS . Patients with NSTE-ACS had a significantly higher incidence of diabetes mellitus and personal history of ischaemic heart disease than those who had a STE-ACS. Significantly higher levels of fibrinogen, C-reactive protein, GoT and GPT were obtained in patients with STE-ACS. The multivariate analysis showed that diabetes mellitus and a personal history were more frequent in NSTE-ACS, while fibrinogen levels were higher in those who had STE-ACS. Conclusions. NSTE-ACS is more frequent in patients with diabetes and those with a personal history of ischaemic heart disease. Of the parameters studied, fibrinogen was found to be significantly higher in patients with STE-ACS (AU)</dc:description>
<dc:creator>Bosch-Benítez, Elvira</dc:creator>
<dc:creator>López-Ríos, Laura</dc:creator>
<dc:creator>Rodríguez-González, Fayna</dc:creator>
<dc:creator>Martínez-Quintana, Efrén</dc:creator>
<dc:creator>Cuba-Herrera, Javiel</dc:creator>
<dc:creator>Nieto-Lago, Vicente</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción y objetivos. En el síndrome coronario agudo se produce un fenómeno inflamatorio con alteración de diversos marcadores analíticos. Su conocimiento podría ayudarnos a estratificar mejor el riesgo y a elegir el tratamiento más adecuado. Métodos. Se estudió a 151 pacientes consecutivos ingresados con síndrome coronario agudo sin elevación del ST (SCASEST) y síndrome coronario agudo con elevación del ST (SCACEST). Se determinaron los factores de riesgo cardiovascular clásicos (diabetes mellitus, hipertensión arterial, hipercolesterolemia, antecedentes familiares y personales de cardiopatía isquémica y tabaquismo) y diversos marcadores analíticos entre los que se incluyeron la insulinemia, el fibrinógeno, la proteína C reactiva, la lipoproteína (a) y la velocidad de sedimentación globular. Resultados. Del total de pacientes, 88 (58,3%) presentaron SCASEST y 63 (41,7%), SCACEST. Los pacientes con SCASEST tuvieron de forma significativa una incidencia mayor de diabetes mellitus y de antecedentes personales de cardiopatía isquémica que los que presentaron SCACEST. En los pacientes con SCACEST se obtuvieron de forma significativa cifras más elevadas de fibrinógeno, proteína C reactiva, transaminasa glutamicoxalacética y transaminasa glutámico pirúvica. El análisis multivariante mostró que la diabetes mellitus y los antecedentes personales eran más frecuentes en pacientes con SCASEST, mientras que los valores de fibrinógeno eran más elevados en pacientes con SCACEST. Conclusiones. Los pacientes diabéticos y con antecedentes personales de cardiopatía isquémica presentaron SCASEST de forma más frecuente. De los parámetros estudiados, el fibrinógeno se encontró de forma significativa más elevado en los pacientes con SCACEST (AU)</dc:description>
<dc:source>Clín. investig. arterioscler. (Ed. impr.);21(4): 179-184, jul.-ago. 2009. tab</dc:source>
<dc:identifier>ibc-114971</dc:identifier>
<dc:title xml:lang="es">Biomarcadores en los síndromes coronarios agudos con y sin elevación del ST</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d22179^s22002</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d22124^s22002</dc:subject>
<dc:subject>^d2359^s22032</dc:subject>
<dc:subject>^d52613^s22032</dc:subject>
<dc:subject>^d23568^s22002</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d28571</dc:subject>
<dc:subject>^d4634^s22074</dc:subject>
<dc:type>article</dc:type>
<dc:date>200908</dc:date>
</metadata>
</record>
</ibecs-document>
